Pyxis Oncology, Inc. (PYXS)
NASDAQ: PYXS · Real-Time Price · USD
1.640
-0.020 (-1.20%)
Apr 20, 2026, 9:58 AM EDT - Market open
Pyxis Oncology Market Cap
Pyxis Oncology has a market cap or net worth of $103.04 million as of April 20, 2026. Its market cap has increased by 64.02% in one year.
Market Cap
103.04M
Enterprise Value
56.12M
1-Year Change
64.02%
Ranking
Category
Stock Price
$1.64
Market Cap Chart
Since the IPO on October 1, 2021, Pyxis Oncology's market cap has decreased from $523.75M to $103.04M, a decrease of -80.33%. That is a compound annual growth rate of -30.07%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 17, 2026 | 104.30M | 45.66% |
| Dec 31, 2025 | 71.60M | -22.81% |
| Dec 31, 2024 | 92.77M | 16.32% |
| Dec 29, 2023 | 79.75M | 70.77% |
| Dec 30, 2022 | 46.70M | -86.78% |
| Dec 31, 2021 | 353.33M | -32.54% |
| Oct 1, 2021 | 523.75M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Coya Therapeutics | 112.13M |
| Verrica Pharmaceuticals | 108.57M |
| Sangamo Therapeutics | 108.54M |
| Aldeyra Therapeutics | 108.33M |
| Cognition Therapeutics | 106.33M |
| Gossamer Bio | 104.67M |
| ProMIS Neurosciences | 103.40M |
| Turn Therapeutics | 103.07M |